VIM and neoplasm: We favor the view that our observations are the result of targeting the non-neoplastic tumor vasculature and not the tumor cells themselves, as the vimentin-excreting tumor endothelial cells are genetically more stable than highly mutating tumor cells and do not easily mutate into resistant variants.